Hemarina
PrivateLast Round
VC Round
Feb 1, 2021
Total Funding Raised
$8.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hemarina is a biotechnology company that develops universal therapeutic oxygen carriers derived from marine origin for medical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemarina Comparables
Compare Hemarina with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VirTech Bio | 84% | |
| Targa Biomedical | 79% | |
| Bridge to Life | 78% |
Hemarina Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 1, 2021 | ||||
| VC Round | Mar 9, 2017 | ||||
| VC Round | Mar 26, 2014 | ||||
| Series B | Jul 13, 2012 | ||||
| Series A | Feb 9, 2009 |
Key People
Founding team and executive leadership
Hemarina Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arkéa Capital | Series B |
| Les Business Angels des Grandes Écoles | VC Round |
| Finistère Angels | VC Round, Series B |
| Inserm Transfert | Series A, Series B |
| Armor Angels | VC Round, Series B |
| Les Business Angels des Grandes Ecoles | VC Round |
| Crédit Mutuel Innovation | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Open roles increased to 4, 4x the trailing average.
- May 16, 2026
Monthly visitors increased 32% MoM, reaching 2.5K.
Hemarina Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hemarina's valuation, stock price, and market status.
Is Hemarina a public or private company?
Hemarina is a private company.
What is the current stock price of Hemarina?
Hemarina is a private company with no public stock price. No recent secondary market data is available.
How much is Hemarina worth (valuation)?
Valuation information for Hemarina is not publicly available.
Can I buy Hemarina stock?
Hemarina shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hemarina's last funding round?
Hemarina's most recent funding round was VC Round on February 1, 2021.
Who are the main investors in Hemarina?
Key investors in Hemarina include Crédit Mutuel Innovation.
Will Hemarina IPO soon?
No public IPO plans have been announced for Hemarina.
How can I track Hemarina secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hemarina's secondary market activity and sign up for updates.